-
Mashup Score: 20Gift of Gratitude: Woman returns to cherished horses after cancer and transplant at Mayo Clinic - Mayo Clinic Comprehensive Cancer Center Blog - 5 month(s) ago
Paula Quinn didn’t know if she’d ever ride horses again after treatment for an aggressive form of non-Hodgkin’s lymphoma damaged […]
Source: cancerblog.mayoclinic.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Lymphoma Daily - 2 year(s) ago
Content directly from sources and does not necessarily reflect my views by Jason R Westin
Source: paper.liCategories: Hem/Oncs, Latest HeadlinesTweet-
The latest Lymphoma Daily! https://t.co/IQOYL7ogu2 Thanks to @AaronGoodman33 @knowyournodes @JeromeCoutet #lymphoma #nonhodgkinslymphoma
-
-
Mashup Score: 0Lymphoma Daily - 2 year(s) ago
Content directly from sources and does not necessarily reflect my views by Jason R Westin
Source: paper.liCategories: Hem/Oncs, Latest HeadlinesTweet-
The latest Lymphoma Daily! https://t.co/ZYNXTM7jbR Thanks to @BiotechWorld @MAPICC2021 @TraderSmarts #nonhodgkinslymphoma #glyphosate
-
-
Mashup Score: 1
Tycel Phillips, MD, University of Michigan, Ann Arbor, MI, discusses some findings from a Phase I trial investigating the safety…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Tycel Phillips of @umichmedicine shares some updates on the safety and efficacy of plamotamab in the treatment of NHL subtypes: 👉https://t.co/eiiGOll4ar👈 #ASH21 @ASH_hematology #HemOnc #LymSM #Lymphoma #ImmunoOnc #NonHodgkinsLymphoma #DLBCL #MantleCellLymphoma
-
-
Mashup Score: 2Podcast-Karuppiah Kannan, PhD @TakedaPharma #ASH21 #Non - 2 year(s) ago
Karuppiah Kannan, Ph.D. Senior Director – Global Program Leader at Takeda Oncology speaks about the ASH 2021 Abstracts – 2488 TAK-981, a First-in-Class SUM
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Podcast - ASH 2021 Abstracts 2488 And 2742 SUMO-Activating Enzyme Inhibitor Karuppiah Kannan, PhD @TakedaPharma #ASH21 #NonHodgkinsLymphoma #MultipleMyeloma #Cancer #Research Link to Audio: https://t.co/lqrUm5BKn6 https://t.co/UQEvJ7VBPe
-
-
Mashup Score: 2Karuppiah Kannan, PhD @TakedaPharma #ASH21 #NonHodgkins - 2 year(s) ago
Karuppiah Kannan, Ph.D. Senior Director – Global Program Leader at Takeda Oncology speaks about the ASH 2021 Abstracts – 2488 TAK-981, a First-in-Class SUM
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
ASH 2021 Abstracts 2488 And 2742 SUMO-Activating Enzyme Inhibitor Karuppiah Kannan, PhD @TakedaPharma #ASH21 #NonHodgkinsLymphoma #MultipleMyeloma #Cancer #Research https://t.co/sDZ4IlyT5G https://t.co/pdlK82KBXL
-
-
Mashup Score: 0Lymphoma Daily - 2 year(s) ago
Content directly from sources and does not necessarily reflect my views by Jason R Westin
Source: paper.liCategories: Hem/Oncs, Latest HeadlinesTweet-
The latest Lymphoma Daily! https://t.co/2c6nkq6VIT Thanks to @DrRichardJLin @TGTherapeutics @medivizor #nonhodgkinslymphoma #hodgkin
-
-
Mashup Score: 0Lymphoma Daily - 2 year(s) ago
Content directly from sources and does not necessarily reflect my views by Jason R Westin
Source: paper.liCategories: Hem/Oncs, Latest HeadlinesTweet-
The latest Lymphoma Daily! https://t.co/7IOcjL4JFu Thanks to @medivizor @lymphomahub @BloodCancerNews #lymphoma #nonhodgkinslymphoma
-
-
Mashup Score: 0Theresa Deisher, PhD @avmbiotech #NonHodgkinsLym … · - 2 year(s) ago
Theresa Deisher, Ph.D. from AVM Biotechnology speaks about FDA Approves Accelerated Dosing in Non-Hodgkin’s Lymphoma/Leukemia Clinical Trial.Link to Arti
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Podcast - FDA Approves Accelerated Dosing in Non-Hodgkin’s Lymphoma/Leukemia Clinical Trial Theresa Deisher, PhD @avmbiotech #NonHodgkinsLymphoma #Leukemia #Cancer #Research Link to Audio: https://t.co/moSBnKSeiw https://t.co/b5BNha51P8
-
-
Mashup Score: 1Lymphoma Daily - 2 year(s) ago
Content directly from sources and does not necessarily reflect my views by Jason R Westin
Source: paper.liCategories: Hem/Oncs, Latest HeadlinesTweet-
The latest Lymphoma Daily! https://t.co/GH1mz0CIVC Thanks to @power4patients @medivizor @ASH_hematology #nonhodgkinslymphoma #dlbcl
-
Paula Quinn didn't know if she'd ever ride horses again after treatment for an aggressive form of #NonHodgkinsLymphoma damaged her heart. But a transplant gave her a second chance: https://t.co/qFckJjxV6p @MayoCancerCare